Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IL-6 Inhibitors and Drug-drug Interactions in Rheumatoid Arthritis
NCT04842981Phase 2Terminated
- Sponsor
- University of Southern Denmark
- Start
- May 2021
- Primary completion
- Sep 2022
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 2 trial of tocilizumab, sarilumab in rheumatoid arthritis (RA), sponsored by University of Southern Denmark. Started May 2021; status: terminated.
02
Drugs
tocilizumabsarilumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT04842981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04842981.